Jounce Therapeutics Stock (NASDAQ: JNCE)
|Day Range2.14 - 2.42||52 Wk Range2.12 - 8.8||Open / Close2.2 / 2.34||Float / Outstanding45.7M / 51.7M|
|Vol / Avg.689.3K / 242K||Mkt Cap121M||P/E-||50d Avg. Price3.61|
|Div / Yield-||Payout Ratio-||Total Float45.7M||EPS-0.65|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Jounce Therapeutics (NASDAQ: JNCE) through any online brokerage.
The latest price target for Jounce Therapeutics (NASDAQ: JNCE) was reported by Raymond James on Wednesday, August 31, 2022. The analyst firm set a price target for 16.00 expecting JNCE to rise to within 12 months (a possible 583.76% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Jounce Therapeutics (NASDAQ: JNCE) is $2.34 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Jounce Therapeutics.
Jounce Therapeutics’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Jounce Therapeutics.
Jounce Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.